d’Abadie, P.; Walrand, S.; Lhommel, R.; Hesse, M.; Borbath, I.; Jamar, F.
Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Curr. Oncol. 2022, 29, 2422-2434.
https://doi.org/10.3390/curroncol29040196
AMA Style
d’Abadie P, Walrand S, Lhommel R, Hesse M, Borbath I, Jamar F.
Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Current Oncology. 2022; 29(4):2422-2434.
https://doi.org/10.3390/curroncol29040196
Chicago/Turabian Style
d’Abadie, Philippe, Stephan Walrand, Renaud Lhommel, Michel Hesse, Ivan Borbath, and François Jamar.
2022. "Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria" Current Oncology 29, no. 4: 2422-2434.
https://doi.org/10.3390/curroncol29040196
APA Style
d’Abadie, P., Walrand, S., Lhommel, R., Hesse, M., Borbath, I., & Jamar, F.
(2022). Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Current Oncology, 29(4), 2422-2434.
https://doi.org/10.3390/curroncol29040196